| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash (used in) / provided by operating activities | -6,511 | -8,004 |
| Issuance of shares, options exercise | 1,985 | 186 |
| Cash paid for taxes on restricted share release | 161 | 111 |
| Net cash provided by / (used in) financing activities | 1,824 | 75 |
| (decrease) / increase in cash and cash equivalents | -4,687 | -7,929 |
| Cash and cash equivalents at beginning of period | 26,634 | - |
| Cash and cash equivalents at end of period | 21,947 | - |
FENNEC PHARMACEUTICALS INC. (FENC)
FENNEC PHARMACEUTICALS INC. (FENC)